VIROLOGIX CORPORATION
666 Third Avenue, 30th Floor
New York, New York 10017
May 14, 1997
By Fax (202-942-9527) and EDGAR
Andrew A. Gerber, Esq.
Mail Stop 7-7
Securities and Exchange Commission
450 Fifth Street N.W.
Washington, D.C. 20549
Re: Registration Statement on Form SB-2
Registration No. 333-16677
Dear Mr. Gerber:
Pursuant to Rule 477(a) of the Securities Act of 1933, as amended,
Virologix Corporation (the "Company") hereby withdraws the above-referenced
Registration Statement. As you have discussed with our counsel, Jeffrey D.
Abbey, Esq., the Underwriter has not been able to complete the offering. No
securities included in the Registration Statement have been sold.
Please be advised that the Company is also withdrawing its Request for
Confidential Treatment for portions of documents filed as Exhibit 10(a) to the
Registration Statement.
Finally, the Company is also withdrawing its Form 8-A which was filed on
March 24, 1997.
If you have any questions, please do not hesitate to call the undersigned
or our counsel, Jeffrey D. Abbey, Esq., (212) 986-2468.
Very truly yours,
VIROLOGIX CORPORATION
By: /s/ Peter V. Golikov
-----------------------------------------
Peter V. Golikov, President
By: /s/ Judson A. Cooper
-----------------------------------------
Judson A. Cooper, Chief Financial Officer
